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We present a unique case of a patient with anti–dipeptidyl peptidase-like protein 6 (DPPX)
encephalitis in which severe pruritus was the cardinal symptom. Anti-DPPX encephalitis is
caused by cell surface autoantigens to DPPX, a subunit of the Kv4.2 potassium channel.1 Most
patients had a combination of limbic encephalitis, brainstem dysfunction, diarrhea, and weight
loss.1–3 We describe a patient with severe pruritus and provide long-term follow-up, oﬀering
recommendations for treatment.
Case presentation
A 57-year-old patient presented with a variety of complaints, developing over months. These
started with gastrointestinal symptoms (diarrhea and abdominal pain). Blastocystis hominis
infection was cultured in stool, but without improvement to treatment. Five months later, he
developed cognitive decline and severe pruritus with allodynia centered on his trunk. There was
severe self-neglect. Our patient was admitted on and oﬀ neuropsychiatric wards for 3 years.
During progression, he also developed myoclonic jerks, autonomic failure, rigidity, and ataxia.
On neurologic examination, his consciousness was clear. The muscle tone was slightly rigid.
There was severe rigidity of the trunk muscles, slight rigidity of the extremities, and antecollis.
He had action myoclonus and hyperekplexia. His gait was remarkably “marionette-like,” and
broad-based, tandem gate was impossible. Deep tendon reﬂexes of the legs were diminished.
He had scratching marks from pruritus centered on his trunk and could not bear clothing.
Neurocognitive testing revealed psychomotor slowing on all tasks. Brain MRI showed bilateral
temporal lobe atrophy and an aspeciﬁc white matter lesion. EEG showed slight background
slowing. Routine blood examination was normal. CSF analysis showed mild lymphocytosis
(12 cells/μL), a slightly elevated protein level (0.52 g/L), and matched oligoclonal bands.
Extensive ancillary examinations (among others, CT-thorax/abdomen, bone marrow biopsy,
and serologic tests on lues, borrelia, and HIV) were all normal. A diagnosis of progressive
encephalomyelitis with rigidity and myoclonus (PERM) was established. Subsequent testing
for DPPX antibodies was positive in both serum and CSF cell-based assays and conﬁrmed by
neuropil staining on immunohistochemistry. Other autoimmune antibodies were negative. A
skin biopsy from the symptomatic lumbar region showed a normal intraepidermal nerve ﬁber
density for this region.
After the start of immunosuppressive therapy, our patient improved, but several relapses
followed. Multiple immunosuppressive agents were tried, and only after adequate treatment
with cyclophosphamide and rituximab, aiming for complete B-cell depletion, our patient
improved markedly without any further relapses to the present (ﬁgure). Two and a half years
after the diagnosis of PERM, our patient developed B-cell non-Hodgkin lymphoma (NHL).
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Discussion
PERM is a syndrome that is believed to result from brainstem
and spinal cord dysfunction. Patients with PERM often have
glycine receptor antibodies or in a minority anti-GAD65
antibodies.4 Only recently, the association with anti-DPPX
antibodies and PERM has been described.5 These cases were
characterized mainly by CNS symptoms and autonomic
dysfunction, while pruritus was a minor symptom.2 By con-
trast, in our patient pruritus, that was refractory to dermato-
logical treatments (reviewed elsewhere) was the cardinal
symptom.6
Anatomically, two pruritus-sensitive aﬀerent pathways exist
(histamine- and cowhage-stimulated pathways). From the
level of the dorsal horn, the pathway travels in the contra-
lateral spinothalamic tract and synapse onto neurons in the
thalamus. The role of Kv4.2 in neurogenic pruritus is not
exactly known. Genetic elimination of Kv4.2 inmice increased
excitability of dorsal horn neurons resulting in enhanced
sensitivity to tactile and thermal stimuli and might explain its
role in neurogenic itch.7
In our patient, the normal intraepidermal nerve ﬁber density
and the absence of an eﬀect from dermatological treatments
suggest pruritus was of central origin located at the dorsal
horn induced by anti-DPPX antibodies.
In line with other forms of autoimmune encephalitis (AIE),
such as anti-Caspr2 encephalitis, anti-DPPX encephalitis
is less subacute, resembling a neurodegenerative disease.
Fulminant and rapidly progressive (autonomic or sensory)
symptoms have been attributed to paraneoplastic neuropathy
associated with Hu or amphiphysin antibodies. In contrast to
other AIEs, such as anti-NMDA receptor encephalitis,
patients with anti-DPPX encephalitis tend to need prolonged
immunosuppressive therapy. As illustrated by our case, every
attempt to taper immunosuppressive therapy resulted in
a very rapid decline. This necessitates the use of chronic im-
munosuppressive therapy, and complete B-cell depletion
seems necessary.
B-cell NHL is associated with chronic immunosuppressive
therapy. B-cell neoplasms developed in 3/39 patients with
anti-DPPX encephalitis, remitting after rituximab.2,3 In our
case, the delayed diagnosis of B-cell NHL could have been
masked by treatment (steroids and rituximab). Therefore, it is
important to perform diagnostic tests in advance of immu-
nosuppressive therapy and during follow-up, especially during
relapses.
Figure Forty-twomonths of follow-up of clinical symptoms in parallel with therapeutic interventions and antibody titers/
B-cell count
(A) Symptom severity. (B) Medication overview. (C) Antibody titers/B-cell counts. AZA = azathioprine; CPP = cyclophosphamide; DPPX = dipeptidyl peptidase-
like protein 6; IVIG = IV immunoglobulin; MP IV = IV methylprednisolone; PLEX = plasma exchange; PREDN = prednisone; RTX = rituximab.
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